Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 9:31 pm | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 15,843 | $3.8449 | $60,915 | 958,941 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:30 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 56,910 | $3.845 | $218,819 | 6,836,490 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:29 pm | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 15,870 | $3.8414 | $60,963 | 301,530 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:26 pm | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 12,477 | $3.8394 | $47,904 | 207,623 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:25 pm | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:24 pm | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 14,029 | $3.843 | $53,913 | 354,162 (Direct) | View |
| 2022-11-11 Sale | 2022-11-15 8:00 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 41,666 | $5.1525 | $214,685 | 778,353 (Direct) | View |
| 2021-12-20 Purchase | 2021-12-21 9:41 pm | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 12,000 | $8.5663 | $102,796 | 23,295 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Exercise | 2024-02-02 9:31 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 44,367 | $0 | 958,941 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:31 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 200,000 | $0 | 958,941 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:30 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 173,467 | $0 | 6,836,490 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:30 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 448,000 | $0 | 6,836,490 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:29 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 41,534 | $0 | 301,530 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:29 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 192,800 | $0 | 301,530 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:26 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 33,334 | $0 | 207,623 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:26 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 120,100 | $0 | 207,623 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:25 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,334 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:25 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 132,800 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:24 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 46,800 | $0 | 354,162 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:24 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 225,200 | $0 | 354,162 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:38 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:35 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 299,100 | $0 | 299,100 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:33 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 1,249,000 | $0 | 1,249,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:30 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 319,400 | $0 | 319,400 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:28 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 337,000 | $0 | 337,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:26 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:49 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:48 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:47 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:47 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:45 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:45 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 378,033 | $0 | 378,033 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 181,000 | $0 | 181,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:36 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:36 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:35 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:34 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:30 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 6:27 pm | N/A 2031-05-17 | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 56,670 | $0 | 56,670 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:56 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 640,000 | $0 | 640,000 (Direct) | View |